115 related articles for article (PubMed ID: 37948339)
21. Transient increased expression of VEGF and MMP-1 in a rat liver tumor model after hepatic arterial occlusion.
Guo WJ; Li J; Chen Z; Zhuang JY; Gu WH; Zhang L; Pang J; Lu CH; Zhang WZ; Cheng YF
Hepatogastroenterology; 2004; 51(56):381-6. PubMed ID: 15086165
[TBL] [Abstract][Full Text] [Related]
22. Effectiveness of Concomitant Chemoradiotherapy with Gemcitabine in Locally Advanced Cervical Cancer Patients with Comorbidities.
Brau-Figueroa H; Arango-Bravo E; Castro-Eguiluz D; Galicia-Carmona T; Lugo-Alferez LA; Cruz-Bautista I; Jiménez-Lima R; Cetina-Pérez L
Cancer Res Treat; 2022 Apr; 54(2):554-562. PubMed ID: 34384015
[TBL] [Abstract][Full Text] [Related]
23. Neoadjuvant Chemotherapy With Cisplatin and Gemcitabine Followed by Chemoradiation Versus Chemoradiation for Locally Advanced Cervical Cancer: A Randomized Phase II Trial.
da Costa SCS; Bonadio RC; Gabrielli FCG; Aranha AS; Dias Genta MLN; Miranda VC; de Freitas D; Abdo Filho E; Ferreira PAO; Machado KK; Scaranti M; Carvalho HA; Estevez-Diz MDP
J Clin Oncol; 2019 Nov; 37(33):3124-3131. PubMed ID: 31449470
[TBL] [Abstract][Full Text] [Related]
24. Usefulness of VEGF, MMP-2, MMP-3 and TIMP-2 serum level evaluation in patients with adrenal tumours.
Kolomecki K; Stepien H; Bartos M; Kuzdak K
Endocr Regul; 2001 Mar; 35(1):9-16. PubMed ID: 11308991
[TBL] [Abstract][Full Text] [Related]
25. Serum vascular endothelial growth factor C (VEGF-C) as a specific biomarker for advanced cervical cancer: Relationship to insulin-like growth factor II (IGF-II), IGF binding protein 3 (IGF-BP3) and VEGF-A [corrected].
Mathur SP; Mathur RS; Gray EA; Lane D; Underwood PG; Kohler M; Creasman WT
Gynecol Oncol; 2005 Sep; 98(3):467-83. PubMed ID: 15982726
[TBL] [Abstract][Full Text] [Related]
26. The combination assay with circulating vascular endothelial growth factor (VEGF)-C, matrix metalloproteinase-9, and VEGF for diagnosing lymph node metastasis in patients with non-small cell lung cancer.
Tamura M; Oda M; Matsumoto I; Tsunezuka Y; Kawakami K; Ohta Y; Watanabe G
Ann Surg Oncol; 2004 Oct; 11(10):928-33. PubMed ID: 15383417
[TBL] [Abstract][Full Text] [Related]
27. [Effect of concurrent chemoradiotherapy on serum vascular endothelial growth factor in esophageal squamous cell carcinoma patients--a report of 43 cases].
Wang XS; Liu MZ; Zhang CQ; Cai L; Cui NJ
Ai Zheng; 2006 Nov; 25(11):1428-32. PubMed ID: 17094915
[TBL] [Abstract][Full Text] [Related]
28. Efficacy of radiotherapy on intermediate and advanced lung cancer and its effect on dynamic changes of serum vascular endothelial growth factor and matrix metalloproteinase-9.
Ding G; Liu Y; Liang C
Oncol Lett; 2018 Jul; 16(1):219-224. PubMed ID: 29928404
[TBL] [Abstract][Full Text] [Related]
29. [Efficacy of Shenyi Capsule combined with gemcitabine plus cisplatin in treatment of advanced esophageal cancer: a randomized controlled trial].
Huang JY; Sun Y; Fan QX; Zhang YQ
Zhong Xi Yi Jie He Xue Bao; 2009 Nov; 7(11):1047-51. PubMed ID: 19912736
[TBL] [Abstract][Full Text] [Related]
30. Antiangiogenic effect of somatostatin receptor subtype 2 on pancreatic cancer cell line: Inhibition of vascular endothelial growth factor and matrix metalloproteinase-2 expression in vitro.
Kumar M; Liu ZR; Thapa L; Chang Q; Wang DY; Qin RY
World J Gastroenterol; 2004 Feb; 10(3):393-9. PubMed ID: 14760765
[TBL] [Abstract][Full Text] [Related]
31. Human Plasma Levels of Vascular Endothelial Growth Factor, Matrix Metalloproteinase 9, and Tissue Inhibitor of Matrix Metalloproteinase 1 and Their Applicability as Tumor Markers in Diagnoses of Cervical Cancer Based on ROC Analysis.
Zajkowska M; Zbucka-Krętowska M; Sidorkiewicz I; Lubowicka E; Będkowska GE; Gacuta E; Szmitkowski M; Ławicki S
Cancer Control; 2018; 25(1):1073274818789357. PubMed ID: 30037277
[TBL] [Abstract][Full Text] [Related]
32. A clinical Comparison of Lobaplatin or Cisplatin with Mitomycine and Vincristine in Treating Patients with Cervical Squamous Carcinoma.
Li WP; Liu H; Chen L; Yao YQ; Zhao EF
Asian Pac J Cancer Prev; 2015; 16(11):4629-31. PubMed ID: 26107215
[TBL] [Abstract][Full Text] [Related]
33. Role of Matrix Metalloproteinase-2, Matrix Metalloproteinase-9, and Vascular Endothelial Growth Factor in the Development of Chronic Subdural Hematoma.
Hua C; Zhao G; Feng Y; Yuan H; Song H; Bie L
J Neurotrauma; 2016 Jan; 33(1):65-70. PubMed ID: 25646653
[TBL] [Abstract][Full Text] [Related]
34. Over-expression of VEGF and MMP-9 in residual tumor cells of hepatocellular carcinoma after embolization with lipidol.
Shi YL; Xu T; Li LP; Chen XP
J Huazhong Univ Sci Technolog Med Sci; 2013 Feb; 33(1):90-95. PubMed ID: 23392714
[TBL] [Abstract][Full Text] [Related]
35. Matrix metalloproteinase-9 decreased after chemotherapy in patients with non-small cell lung cancer.
Ertan E; Soydinc H; Yazar A; Ustuner Z; Tas F; Yasasever V
Tumori; 2011; 97(3):286-9. PubMed ID: 21789004
[TBL] [Abstract][Full Text] [Related]
36. Use of nimotuzumab combined with cisplatin in treatment of nasopharyngeal carcinoma and its effect on expressions of VEGF and MMP-2.
Qu L; Wang JH; Du JX; Kang P; Niu XQ; Yin LZ
Clin Transl Oncol; 2021 Jul; 23(7):1342-1349. PubMed ID: 33517541
[TBL] [Abstract][Full Text] [Related]
37. UFT and its metabolite gamma-butyrolactone (GBL) inhibit angiogenesis induced by vascular endothelial growth factor in advanced cervical carcinoma.
Nagai N; Mukai K; Hirata E; Jin HH; Komatsu M; Yunokawa M
Med Oncol; 2008; 25(2):214-21. PubMed ID: 17968681
[TBL] [Abstract][Full Text] [Related]
38. [Expression and clinical significance of matrix metalloproteinase-9 and vascular endothelial growth factor in oral squamous cell carcinomas].
Xu H; Shi XP; Tang WP; Li LX
Ai Zheng; 2002 Sep; 21(9):983-8. PubMed ID: 12508547
[TBL] [Abstract][Full Text] [Related]
39. Pretreatment serum lactate dehydrogenase is an independent prognostic factor for patients receiving neoadjuvant chemotherapy for locally advanced cervical cancer.
Li J; Wu MF; Lu HW; Chen Q; Lin ZQ; Wang LJ
Cancer Med; 2016 Aug; 5(8):1863-72. PubMed ID: 27350066
[TBL] [Abstract][Full Text] [Related]
40. Matrix metalloproteinase 9, apoptosis, and vascular morphology in early arthritis.
Fraser A; Fearon U; Reece R; Emery P; Veale DJ
Arthritis Rheum; 2001 Sep; 44(9):2024-8. PubMed ID: 11592363
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
